IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
30.00
+1.40 (4.90%)
Nov 4, 2024, 4:00 PM EST - Market closed
IDEAYA Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | - | 157.02 | 68.63 | 92.05 | 72.04 | 34.07 | Upgrade
|
| Short-Term Investments | - | 368.1 | 296.2 | 154.72 | 211.55 | 64.89 | Upgrade
|
| Cash & Short-Term Investments | 701.66 | 525.11 | 364.83 | 246.77 | 283.59 | 98.96 | Upgrade
|
| Cash Growth | 49.69% | 43.93% | 47.84% | -12.98% | 186.58% | 10.00% | Upgrade
|
| Receivables | - | 0.02 | 0.21 | 1.1 | 1.88 | - | Upgrade
|
| Prepaid Expenses | - | 7.5 | 5.41 | 3.12 | 3.14 | 2.7 | Upgrade
|
| Total Current Assets | - | 532.63 | 370.45 | 251 | 288.61 | 101.65 | Upgrade
|
| Property, Plant & Equipment | - | 8.41 | 8.99 | 8.66 | 9.48 | 9.7 | Upgrade
|
| Long-Term Investments | - | 107.49 | 8.32 | 121.29 | - | 1.53 | Upgrade
|
| Other Long-Term Assets | - | 0.78 | 0.21 | 0.4 | 0.19 | 0.12 | Upgrade
|
| Total Assets | - | 649.32 | 387.97 | 381.35 | 298.27 | 113 | Upgrade
|
| Accounts Payable | - | 6.6 | 4.28 | 2.1 | 0.95 | 0.71 | Upgrade
|
| Accrued Expenses | - | 18.76 | 17 | 12.32 | 8.52 | 5.02 | Upgrade
|
| Current Portion of Leases | - | 1.75 | 1.87 | 1.7 | 1.54 | 1.15 | Upgrade
|
| Current Unearned Revenue | - | - | 8.57 | 29.04 | 27.61 | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.02 | 0.06 | Upgrade
|
| Total Current Liabilities | - | 27.1 | 31.72 | 45.16 | 38.64 | 6.94 | Upgrade
|
| Long-Term Leases | - | 1.13 | 1.61 | 3.48 | 5.18 | 5.63 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 5.19 | 31.19 | 56.16 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.01 | 0.03 | Upgrade
|
| Total Liabilities | - | 28.23 | 38.51 | 79.83 | 100 | 12.6 | Upgrade
|
| Common Stock | - | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | - | 968.89 | 587.72 | 478.97 | 325.25 | 192.82 | Upgrade
|
| Retained Earnings | - | -348.36 | -235.4 | -176.75 | -126.99 | -92.49 | Upgrade
|
| Comprehensive Income & Other | - | 0.56 | -2.87 | -0.71 | 0.01 | 0.07 | Upgrade
|
| Total Common Equity | 931.66 | 621.09 | 349.46 | 301.51 | 198.27 | 100.4 | Upgrade
|
| Shareholders' Equity | 931.66 | 621.09 | 349.46 | 301.51 | 198.27 | 100.4 | Upgrade
|
| Total Liabilities & Equity | - | 649.32 | 387.97 | 381.35 | 298.27 | 113 | Upgrade
|
| Total Debt | 1.87 | 2.87 | 3.48 | 5.18 | 6.72 | 6.77 | Upgrade
|
| Net Cash (Debt) | 950.86 | 629.73 | 369.66 | 362.88 | 276.86 | 93.71 | Upgrade
|
| Net Cash Growth | 86.79% | 70.35% | 1.87% | 31.07% | 195.45% | 4.17% | Upgrade
|
| Net Cash Per Share | 12.48 | 10.95 | 8.92 | 10.29 | 11.20 | 7.50 | Upgrade
|
| Filing Date Shares Outstanding | 86.19 | 74.56 | 48.39 | 38.63 | 32.25 | 20.33 | Upgrade
|
| Total Common Shares Outstanding | 86.19 | 65.04 | 48.19 | 38.53 | 29.52 | 20.32 | Upgrade
|
| Working Capital | - | 505.53 | 338.74 | 205.84 | 249.97 | 94.71 | Upgrade
|
| Book Value Per Share | 12.24 | 9.55 | 7.25 | 7.82 | 6.72 | 4.94 | Upgrade
|
| Tangible Book Value | 931.66 | 621.09 | 349.46 | 301.51 | 198.27 | 100.4 | Upgrade
|
| Tangible Book Value Per Share | 12.24 | 9.55 | 7.25 | 7.82 | 6.72 | 4.94 | Upgrade
|
| Machinery | - | 12.22 | 10.51 | 7.02 | 5.33 | 4.46 | Upgrade
|
| Leasehold Improvements | - | 3.32 | 3.32 | 3.13 | 2.72 | 2.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.